Literature DB >> 19605870

Highlights of the North American Cystic Fibrosis Conference 2008.

Tom Hilliard1, Kathy Wedlock, Helen McGowan, Charlotte Hayward, Damian Downey.   

Abstract

Entities:  

Mesh：

Year:  2009        PMID： 19605870      PMCID： PMC2711862          DOI： 10.1258/jrsm.2009.s19004

Source DB:  PubMed          Journal:  J R Soc Med        ISSN： 0141-0768            Impact factor:   5.344


× No keyword cloud information.
  4 in total

1.  Intestinal inflammation is a frequent feature of cystic fibrosis and is reduced by probiotic administration.

Authors:  E Bruzzese; V Raia; G Gaudiello; G Polito; V Buccigrossi; V Formicola; A Guarino
Journal:  Aliment Pharmacol Ther       Date:  2004-10-01       Impact factor: 8.171

2.  Effect of Lactobacillus GG supplementation on pulmonary exacerbations in patients with cystic fibrosis: a pilot study.

Authors:  Eugenia Bruzzese; Valeria Raia; Maria Immacolata Spagnuolo; Monica Volpicelli; Giulio De Marco; Luigi Maiuri; Alfredo Guarino
Journal:  Clin Nutr       Date:  2007-03-13       Impact factor: 7.324

3.  Effectiveness of PTC124 treatment of cystic fibrosis caused by nonsense mutations: a prospective phase II trial.

Authors:  Eitan Kerem; Samit Hirawat; Shoshana Armoni; Yasmin Yaakov; David Shoseyov; Michael Cohen; Malka Nissim-Rafinia; Hannah Blau; Joseph Rivlin; Micha Aviram; Gary L Elfring; Valerie J Northcutt; Langdon L Miller; Batsheva Kerem; Michael Wilschanski
Journal:  Lancet       Date:  2008-08-20       Impact factor: 79.321

4.  Cleavage of CXCR1 on neutrophils disables bacterial killing in cystic fibrosis lung disease.

Authors:  Dominik Hartl; Philipp Latzin; Peter Hordijk; Veronica Marcos; Carsten Rudolph; Markus Woischnik; Susanne Krauss-Etschmann; Barbara Koller; Dietrich Reinhardt; Adelbert A Roscher; Dirk Roos; Matthias Griese
Journal:  Nat Med       Date:  2007-12-02       Impact factor: 53.440
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.